Nilemdo ® (bempedoic acid) Daiichi Sankyo Composition: • Available as film-coated tablet containing 180 mg of bempedoic acid Indication: • As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults wi...

The Burden of Chronic Kidney Disease Chronic kidney disease (CKD) is one of the most prominent causes of death and suffering in the 21 st century. The number of patients affected by CKD has substantially increased with an estimate of 843.6 million i...

Chronic kidney disease (CKD) is a global public health problem that an estimated 843.6 million individuals are currently affected by various stages of the disease, whereas the prevalence of CKD is increasing, and Hong Kong is no exception1. Yet, the...

Type 1 diabetes mellitus (T1D) is an autoimmune disease that leads to the destruction of insulin-producing pancreatic beta cells. Practically, management of T1D requires multiple daily insulin injections, insulin pump therapy, or the use of an autom...

The global pandemic of type 2 diabetes (T2D) has increased noticeably over the last few dedicates with an estimated 463 million people affected globally since the 2019, which is projected to increased to 700 million by the year 2045 1 . Notably, T2D...

Moderator Prof. Juliana Chan - Professor of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong Speaker Prof. Didac Mauricio - Professor of Medicine, Faculty of Medicine, University of Vic & Cent...

RYZODEG ® (insulin aspart, insulin degludec) NOVO NORDISK HK Reg. No. HK-68663 (28 Apr, 2025) Composition: 4 • Ryzodeg 100 units/mL FlexTouch solution for injection in pre-filled pen • 1 mL solution contains 100 units insulin degludec/...

LINAGLIPTIN TAISHO ® (linagliptin) TAISHO HK Reg. No. HK-68588 (26 Feb, 2025) Composition: 2 • Linagliptin is available as 5 mg oral tablets Indication: 2 • Linagliptin is used with diet and exercise to help lower blood sugar levels in...

Type 2 diabetes mellitus (T2DM) is a persistent state of hyperglycaemia and glucose intolerance that occurs when the body cannot effectively respond to insulin. 14% of adults aged 18 or older were living with diabetes globally in 2022, whereas that ...

GLUCOPHAGE XR ® (metformin hydrochloride) MERCK HK Reg. No. HK-68753 (14 Jul, 2025) Composition: 2 • One prolonged release tablet contains 500 mg metformin hydrochloride corresponding to 390 mg metformin base Indication: 2 • Reduction ...

Despite semaglutide’s proven efficacy, a recent Danish study has revealed a surprising reality: over half of adults stop using the drug within a year. While highly effective at curbing appetite and promoting weight loss, semaglutide’s hi...